Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 11, Pages 417
Publisher
MDPI AG
Online
2018-11-01
DOI
10.3390/cancers10110417
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic ConFUSION: SS18-SSX Fusion Rewires BAF Complex to Activate Bivalent Genes in Synovial Sarcoma
- (2018) Marc A. Morgan et al. CANCER CELL
- Synovial Sarcoma: Current Concepts and Future Perspectives
- (2018) Silvia Stacchiotti et al. JOURNAL OF CLINICAL ONCOLOGY
- The importance of treating by histological subtype in advanced soft tissue sarcoma
- (2017) Javier Martín Broto et al. Future Oncology
- Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine
- (2017) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant chemotherapy in resectable synovial sarcoma
- (2017) Charles C. Vining et al. JOURNAL OF SURGICAL ONCOLOGY
- Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
- (2017) Alessandro Gronchi et al. LANCET ONCOLOGY
- Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
- (2017) Hussein A Tawbi et al. LANCET ONCOLOGY
- Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
- (2017) Federica Recine et al. OncoTargets and Therapy
- Survival changes in Patients with Synovial Sarcoma, 1983-2012
- (2017) Shuncong Wang et al. Journal of Cancer
- Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications
- (2017) Sandro Pasquali et al. Therapeutic Advances in Medical Oncology
- Synovial Sarcoma Recurrence in Children and Young Adults
- (2016) Monika Scheer et al. ANNALS OF SURGICAL ONCOLOGY
- Gemcitabine-based chemotherapy in sarcomas: A systematic review of published trials
- (2016) Agnès Ducoulombier et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity
- (2016) Myrella Vlenterie et al. EUROPEAN JOURNAL OF CANCER
- Prognosis of T1 synovial sarcoma depends upon surgery by oncologic surgeons
- (2016) Marc El Beaino et al. JOURNAL OF SURGICAL ONCOLOGY
- Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
- (2016) William D Tap et al. LANCET
- Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Olivier Mir et al. LANCET ONCOLOGY
- Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas
- (2016) Alessandro De Vita et al. OncoTargets and Therapy
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
- (2015) Brian Hutton et al. ANNALS OF INTERNAL MEDICINE
- Trabectedin in advanced synovial sarcomas
- (2015) Roberta Sanfilippo et al. ANTI-CANCER DRUGS
- Age as an independent prognostic factor for survival of localised synovial sarcoma patients
- (2015) Myrella Vlenterie et al. BRITISH JOURNAL OF CANCER
- Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study
- (2015) Akira Kawai et al. LANCET ONCOLOGY
- Synovial Sarcoma: Recent Discoveries as a Roadmap to New Avenues for Therapy
- (2015) Torsten O. Nielsen et al. Cancer Discovery
- Synovial sarcoma: defining features and diagnostic evolution
- (2014) Khin Thway et al. Annals of Diagnostic Pathology
- Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) ANNALS OF ONCOLOGY
- Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005)
- (2014) A. Ferrari et al. ANNALS OF ONCOLOGY
- A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance
- (2014) Alberto S. Pappo et al. CANCER
- Synovial Sarcoma in Children and Adolescents
- (2014) Anna Kerouanton et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
- (2014) Ian Judson et al. LANCET ONCOLOGY
- Prognostic implication of SYT-SSX fusion type in synovial sarcoma: A multi-institutional retrospective analysis in Japan
- (2014) Satoshi Takenaka et al. ONCOLOGY REPORTS
- Epidemiology and survivorship of soft tissue sarcomas in adults: a national cancer database report
- (2014) Robert M. Corey et al. Cancer Medicine
- Prognostic impact of the activation status of the Akt/mTOR pathway in synovial sarcoma
- (2013) Nokitaka Setsu et al. CANCER
- An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours
- (2013) P. Schöffski et al. EUROPEAN JOURNAL OF CANCER
- Long-term Treatment Outcomes for Patients With Synovial Sarcoma
- (2012) Wenyin Shi et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma
- (2011) A. Gronchi et al. ANNALS OF ONCOLOGY
- Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study
- (2011) Xavier García-del-Muro et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes
- (2011) Patrick Schöffski et al. LANCET ONCOLOGY
- Sparing strategy does not compromise prognosis in pediatric localized synovial sarcoma: Experience of the International Society of pediatric oncology, malignant mesenchymal tumors (SIOP-MMT) Working Group
- (2011) Daniel Orbach et al. PEDIATRIC BLOOD & CANCER
- Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors
- (2010) A. H. Krieg et al. ANNALS OF ONCOLOGY
- Synovial sarcoma
- (2009) Emanuela Palmerini et al. CANCER
- Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules
- (2009) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model
- (2009) Rashmi Chugh et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
- (2009) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group
- (2008) A. Italiano et al. ANNALS OF ONCOLOGY
- A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients
- (2008) R. J. Canter et al. CLINICAL CANCER RESEARCH
- A Phase II Study of Gefitinib for Patients with Advanced HER-1 Expressing Synovial Sarcoma Refractory to Doxorubicin-Containing Regimens
- (2008) I. Ray-Coquard et al. ONCOLOGIST
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started